These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30174434)

  • 1. The European Innovative Medicines Initiative: Progress to Date.
    Faure JE; Dyląg T; Norstedt I; Matthiessen L
    Pharmaceut Med; 2018; 32(4):243-249. PubMed ID: 30174434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Innovative Medicines Initiative -10 Years of Public-Private Collaboration.
    Laverty H; Meulien P
    Front Med (Lausanne); 2019; 6():275. PubMed ID: 31850354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The innovative medicines initiative: a European response to the innovation challenge.
    Goldman M
    Clin Pharmacol Ther; 2012 Mar; 91(3):418-25. PubMed ID: 22318619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
    Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
    Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public-private partnership models in France and in Europe.
    Demotes-Mainard J; Canet E; Segard L
    Therapie; 2006; 61(4):325-34, 313-23. PubMed ID: 17124948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public-private partnerships as driving forces in the quest for innovative medicines.
    Goldman M; Compton C; Mittleman BB
    Clin Transl Med; 2013 Jan; 2(1):2. PubMed ID: 23369569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The innovative medicines initiative: a public private partnership model to foster drug discovery.
    Vaudano E
    Comput Struct Biotechnol J; 2013; 6():e201303017. PubMed ID: 24688725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The European Lead Factory: A Blueprint for Public-Private Partnerships in Early Drug Discovery.
    Karawajczyk A; Orrling KM; de Vlieger JS; Rijnders T; Tzalis D
    Front Med (Lausanne); 2016; 3():75. PubMed ID: 28154815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Innovative Medicines Initiative neurodegeneration portfolio: From individual projects to collaborative networks.
    O'Rourke D; Coll-Padrós N; Bradshaw A; Killin L; Pradier L; Georges J; Dawoud DM; Steukers L; Diaz C
    Front Neurol; 2022; 13():994301. PubMed ID: 36408524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why we need more collaboration in Europe to enhance post-marketing surveillance of vaccines.
    Sturkenboom M; Bahri P; Chiucchiuini A; Grove Krause T; Hahné S; Khromava A; Kokki M; Kramarz P; Kurz X; Larson HJ; de Lusignan S; Mahy P; Torcel-Pagnon L; Titievsky L; Bauchau V;
    Vaccine; 2020 Dec; 38 Suppl 2():B1-B7. PubMed ID: 31677952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance.
    Kostyanev T; Bonten MJ; O'Brien S; Steel H; Ross S; François B; Tacconelli E; Winterhalter M; Stavenger RA; Karlén A; Harbarth S; Hackett J; Jafri HS; Vuong C; MacGowan A; Witschi A; Angyalosi G; Elborn JS; deWinter R; Goossens H
    J Antimicrob Chemother; 2016 Feb; 71(2):290-5. PubMed ID: 26568581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards Better Pharmaceutical Provision in Europe-Who Decides the Future?
    Horgan D; Spanic T; Apostolidis K; Curigliano G; Chorostowska-Wynimko J; Dauben HP; Lal JA; Dziadziuszko R; Mayer-Nicolai C; Kozaric M; Jönsson B; Gutierrez-Ibarluzea I; Fandel MH; Lopert R
    Healthcare (Basel); 2022 Aug; 10(8):. PubMed ID: 36011250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Horizon Europe, research and innovation programme until 2027 - what is new comparing with Horizon 2020?
    Kinkorová J
    Cas Lek Cesk; 2022; 161(3-4):163-166. PubMed ID: 36100458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participating in innovative medicines initiative funded neurodegenerative disorder projects-An impact analysis conducted as part of the NEURONET project.
    Hawksworth C; Salih F; Cresswell K; Steukers L; Diaz C; Killin L; Pradier L; Bradshaw A; Dawoud D
    Front Neurol; 2023; 14():1140722. PubMed ID: 37006486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of public-private collaborative real-world evidence platforms to monitor vaccine performance post authorization: DRIVE - a European initiative.
    Díez-Domingo J; Torcel-Pagnon L; Carmona A; Launay O; Dos Santos G; Rizzo C; Haag M; Stuurman A; Nauta J; Vannacci A; de Lusignan S; Del Rey E; Levi M; Lina B; Bellino S; Nye S; Neels P; Nohynek H; Mahé C;
    Expert Rev Vaccines; 2022 Dec; 21(12):1701-1710. PubMed ID: 36261918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White spots in pharmaceutical pipelines-EMA identifies potential areas of unmet medical needs.
    Papaluca M; Greco M; Tognana E; Ehmann F; Saint-Raymond A
    Expert Rev Clin Pharmacol; 2015 May; 8(3):353-60. PubMed ID: 25797498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidance for the governance of public-private collaborations in vaccine post-marketing settings in Europe.
    Torcel-Pagnon L; Bauchau V; Mahy P; Tin Tin Htar M; van der Sande M; Mahé C; Krause TG; Charrat A; Simondon F; Kurz X;
    Vaccine; 2019 May; 37(25):3278-3289. PubMed ID: 31072735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Innovative Medicines Initiative moves translational immunology forward.
    Goldman M; Wittelsberger A; De Magistris MT
    Eur J Immunol; 2013 Feb; 43(2):298-302. PubMed ID: 23534061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccinology capacity building in Europe for innovative platforms serving emerging markets.
    Hendriks J; Holleman M; Hamidi A; Beurret M; Boog C
    Hum Vaccin Immunother; 2013 Apr; 9(4):932-6. PubMed ID: 23563518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reflections on the Innovative Medicines Initiative.
    Goldman M
    Nat Rev Drug Discov; 2011 May; 10(5):321-2. PubMed ID: 21532547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.